Dorejd Kastrati

Experience

• 

  Novartis Deutschland

  Jan 2005 - Jan 2011

  Achieved significant market share increases with the main drug Exelon Patch.Therapeutic areas: Alzheimer's Disease, Multiple Sclerosis, Children Attention Deficit DisorderTargets: Hospitals, Specialists, General Practitioners & Pharmacies Brand management around the Novartis flagship Valsartan brand family (Diovan, CoDiovan, Exforge, ExforgeHCT) in cardiovascular therapeutic areas (hypertension, heart failure, myocardial infarction). Achieved market leadership in hypertension market 2009. Lead the extended cross-functional launch team around new dosages. Launched the first modern triple combination therapy (exforgeHCT) in Germany. Trained the sales force, created detailing materials and managed legal proceedings.

  • Sales Specialist Neuroscience

    Jan 2009 - Jan 2011

  • Marketing Manager Cardiovascular

    Jan 2005 - Jan 2009
• 

  Novartis Deutschland

  Jan 2012 - Jan 2015

  Led a team of 12 hospital sales specialists in Western Germany and bore responsibility for the therapeutic areas of hemostaseology (Mono-Embolex) and infectious diseases (Cubicin). Built a highly motivated team and achieved market share turnaround. Received highest possible ratings from team and supervisor in the official feedback rounds.Targets: Hospitals, Specialists, General Practitioners & Pharmacies Led a team of 5 brand managers and 2 assistants in Germany. Successfully launched Certican in Liver Transplantation and optimised transplant portfolio (Myfortic, Sandimmun) and infectiology business (Cubicin, Sebivo). Coordinated 4 cross-divisional project workstreams & 10 project leaders. Successfully introduced iPads, new CRM and electronic detail Aids to the complete Novartis sales force in Germany, incl. overarching change management.

  • Regional Sales Manager Primary Care

    Jan 2013 - Jan 2015

  • Head of Marketing Transplant & Infectiology

    Jan 2013 - Jan 2013

  • Head of Program Management, Marketing & Sales Operations

    Jan 2012 - Jan 2013
• 

  Merck KGaA, Darmstadt, Germany

  Jan 2016 - Jan 2016

  Head of Sales Oncology

  Led a team of 40 regional sales managers and hospital sales representatives, managing the sales of the drug Erbitux in colon and head & neck cancer, and Xalkori in lung cancer in co-promotion with Pfizer. Rearranged the sales structure to shift resources in therapeutic areas with higher potential. Developed a new sales training and coaching plan based on competency profile assessment.

• 

  Boehringer Ingelheim

  Jan 2017 - Jan 2023

  Led a team of 20 medical advisors and scientific relations managers dedicated to foster scientific partnerships with medical societies and key experts, steer the investigator-initiated trial program, implement and scale up initiatives that drive guideline implementation, and align portfolio strategy across indications. Constantly overachieved growth target of Trajenta®, a global USD 1.7bn diabetes brand. Developed the brand’s integrated business plans and established the Simplicity framework (the brand’s value proposition). Drove execution excellence and multichannel expansion with focus on China and Emerging Markets. Rolled out two large cardiovascular outcome trials.

  • Associate Head of Medicine, Head of Global Scientific Affairs CardioMetabolism & Respiratory

    Jan 2021 - Jan 2023

  • Global Senior Brand Manager Diabetes

    Jan 2017 - Jan 2021
• 

  Boehringer Ingelheim

  May 2023 - now

  Vice President, Medical Affairs and Clinical Development, Cardio-Renal

  Leading a team of 40 medical affairs strategists, clinical development leads, and field-based medical colleagues. Responsible for US medical strategy of the company's cardio-renal portfolio (in-market and pipeline assets).